about
Surgery plus adjuvant radiotherapy versus surgery alone for stage II endometrial cancerIs There Any Association between Glutathione S-transferases M1 and Glutathione S-transferases T1 Gene Polymorphisms and Endometrial Cancer Risk? A Meta-analysis.Controversies in the management of endometrial cancer.Controversies in the management of endometrial carcinoma.Molecular pathogenesis of endometrial cancers in patients with Lynch syndromeClinic-based case-control study of the association between body mass index and endometrial cancer in Puerto Rican women.ZEB1 expression in endometrial biopsy predicts lymph node metastases in patient with endometrial cancer.Cancer-associated fibroblasts promote proliferation of endometrial cancer cellsThe role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patientsCharacterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinomaUtility of Pelvic MRI and Tumor Markers HE4 and CA125 to Predict Depth of Myometrial Invasion and Cervical Involvement in Endometrial Cancer.Invasive endometrial lesion in a patient with mental retardation.Molecular target therapies in endometrial cancer: from the basic research to the clinic.The use of minimally invasive surgery for endometrial cancer.The occurrence of fetal microchimeric cells in endometrial tissues is a very common phenomenon in benign uterine disorders, and the lower prevalence of fetal microchimerism is associated with better uterine cancer prognoses.Endometrial Assessment: When is it Necessary?Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelinesStromal derived factor-1 (SDF-1) and its receptors CXCR4 and CXCR7 in endometrial cancer patientsFertility-preservation in endometrial cancer: is it safe? Review of the literature.High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma.Lower Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Promotes the Proliferation and Migration of Endometrial Carcinoma.Intraoperative lymphatic mapping techniques for endometrial cancer.MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.Current therapy of patients with endometrial carcinoma. A critical review.Primary bone metastasis as initial presentation of endometrial cancer (stage IVb).Endometrial carcinoma in high-risk populations: is it time to consider a screening policy?Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives.EMMPRIN in gynecologic cancers: pathologic and therapeutic aspects.Inter-observer reproducibility of endometrial cytology by the Osaki Study Group method: utilising the Becton Dickinson SurePath™ liquid-based cytology.Studies on the role of osteopontin-1 in endometrial cancer cell lines.Distribution of lymph node metastasis sites in endometrial cancer undergoing systematic pelvic and para-aortic lymphadenectomy: a proposal of optimal lymphadenectomy for future clinical trials.A molecular carrier to transport and deliver cisplatin into endometrial cancer cells.Effects of N-[N-(3, 5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT) on cell proliferation and apoptosis in Ishikawa endometrial cancer cells.Polymorphisms in cyclooxygenase-2 gene in endometrial cancer patients.Prognostic Impact of ABO Blood Group on Type I Endometrial Cancer Patients- Results from Our Own and Other Studies.Surgical and systemic management of endometrial cancer: an international survey.Rural-urban differences in surgical treatment, regional lymph node examination, and survival in endometrial cancer patients.Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer.Prognostic significance of SUVmax (maximum standardized uptake value) measured by [¹⁸F]FDG PET/CT in endometrial cancer.Clinicopathological significance of increased ZIC1 expression in human endometrial cancer.
P2860
Q24201111-9FCDEA67-3238-4EB7-807D-90735DC9BEBFQ33877853-1BDEEB21-BF91-4145-911E-83FFD8DD3613Q33960860-DA885C57-F823-4C31-8BC1-F56B30562D9FQ33960894-296C3914-D049-4751-8AB8-DF90006CF44DQ33996492-BFC459A0-6A8A-4FC5-AE19-388F19D20005Q34580098-4650FA22-0BAE-4488-889D-1C88EE506832Q34722585-8B5B016C-7EF3-4BE6-8A4C-0EC5B4DD80EFQ34901877-68DC4A8C-E7E8-43F5-A8D2-B36F2F8C7751Q35152277-A6BA5F6C-41F9-4CEC-A6F7-9915D5E0853DQ35519808-DEE39A71-FA39-45A7-A1DE-626FCA585261Q36758285-538660B8-79BC-4542-859F-18E873AB35DBQ36935555-B85796C3-5D32-4311-93A9-0A21A110FC82Q37196543-8CCA623A-CF6D-410D-B7A3-483675FB653CQ37349630-591FDD5F-C8F4-416C-81CA-33A3E4575941Q37433980-FBFA2948-04A2-4630-890D-1CCE2F9E7880Q37438251-FFCC8C3C-6FDC-4838-816E-8B719A8CDF49Q37454445-3BC1F278-C327-4DFF-A51E-340B87E7715FQ37458567-AE101D7B-ECA4-4415-AAAB-F3FAE5FF32DDQ37605349-0B1735DF-9BBC-423E-8BCF-D450889B8BBDQ37627214-2ED051AA-F6E6-4F49-B67B-EA02E247ADAEQ37677195-B70F2C3A-AD66-4643-80D1-CA05CF76B1A6Q37821900-0437A07D-7201-40AA-85A3-97DE4BDE4FA4Q37872630-781C9F33-C9F2-40F2-A1FA-3B187AB358B9Q37970571-ADBB63E0-A3CD-4348-9AE1-81143ED61BEDQ38125407-BE7D904F-4973-4759-84D0-94A05EAC7921Q38182148-A58A33DD-C4A1-48D1-8003-99002A31FB9CQ38244309-265119A4-5E00-46CC-BF4D-E12D4B8BC21FQ38476060-7B2D955A-D37D-4DE8-88FE-0236AA4093CBQ38816163-281A75A4-423F-451F-98F1-155E02AD5185Q39078328-A9FB4803-DB79-4FC0-86E0-2F500C9CF57DQ39215139-B4518FB0-682B-43EE-BEC6-89C4BE7FE301Q39409872-6BA0CFD6-4611-41AC-99ED-8B165A4D22E4Q39424394-9CA27C54-7B0A-4A9C-B302-A5406DE48E16Q41030946-8E68F5EF-91AB-455B-ADC1-560E5C65D34CQ41721752-6FA8075C-7A97-495F-BDE9-25C7E1F15D10Q44050070-B0204748-3245-4B76-9E4B-19A79444E4E7Q47241035-03C0A1B5-F75E-45FA-B70D-D81DD7CC9B09Q53017777-4A1B07EE-8C98-4858-A789-34FB61D33365Q53174382-B9F74679-BFCC-44CC-9770-D04AA06A33D1Q53209410-893D6400-5573-4ABC-B312-A34F9797C109
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current issues in the management of endometrial cancer.
@en
Current issues in the management of endometrial cancer.
@nl
type
label
Current issues in the management of endometrial cancer.
@en
Current issues in the management of endometrial cancer.
@nl
prefLabel
Current issues in the management of endometrial cancer.
@en
Current issues in the management of endometrial cancer.
@nl
P2093
P356
P1476
Current issues in the management of endometrial cancer
@en
P2093
Andrea Mariani
Jamie N Bakkum-Gamez
Nadia N Laack
Sean C Dowdy
P304
P356
10.4065/83.1.97
P407
P577
2008-01-01T00:00:00Z